{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:37:55Z","timestamp":1783489075774,"version":"3.55.0"},"reference-count":33,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Adipose tissue\u2013derived signals potentially link obesity and adipose tissue dysfunction with metabolic and cardiovascular diseases. Although some adipocytokines have been closely related to metabolic and cardiovascular traits, it is unknown which adipocytokine or adipocytokine clusters serve as meaningful markers of metabolic syndrome (MS) components. Therefore, this study investigated the associations of 12 adipocytokines with components of the MS to identify the most relevant cytokines potentially related to specific metabolic profiles.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research Design and Methods<\/jats:title>\n                  <jats:p>Twelve cytokines [adiponectin, adipocyte fatty acid\u2013binding protein (AFABP), angiopoietin-related growth factor, chemerin, fibroblast growth factor (FGF) 19, FGF21, FGF23, insulin-like growth factor-1, interleukin 10, irisin, progranulin, and vaspin] were quantified in a cross-sectional cohort of 1046 subjects. Hypothesis-free cluster analysis, multivariate regression analyses with parameters of the MS, and discriminant analysis were performed to assess associations and the relative importance of each cytokine for reflecting MS and its components.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among the studied adipocytokines, adiponectin, AFABP, chemerin, and FGF21 showed the strongest associations with MS and several MS components in discriminant analyses and multiple regression models. For certain metabolic components, these adipocytokines were better discriminators than routine metabolic markers. Other cytokines investigated in the present cohort are less able to distinguish between metabolically healthy and unhealthy subjects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Adiponectin, AFABP, chemerin, and FGF21 showed the strongest associations with MS components in a general population, suggesting that adverse adipose tissue function is a major contributor to these metabolic abnormalities. Future prospective studies should address the question whether these adipocytokines can predict the development of metabolic disease states.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2017-02085","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T15:01:02Z","timestamp":1515596462000},"page":"1015-1023","source":"Crossref","is-referenced-by-count":65,"title":["Relationship Between 12 Adipocytokines and Distinct Components of the Metabolic Syndrome"],"prefix":"10.1210","volume":"103","author":[{"given":"Thomas","family":"Ebert","sequence":"first","affiliation":[{"name":"University of Leipzig, Department of Endocrinology and Nephrology, Leipzig, Germany"},{"name":"Leipzig University Medical Center, Integrated Research and Treatment Center (IFB) AdiposityDiseases, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gebhardt","sequence":"additional","affiliation":[{"name":"University of Leipzig, Department of Endocrinology and Nephrology, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Scholz","sequence":"additional","affiliation":[{"name":"Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany"},{"name":"Leipzig Research Centre for Civilization Diseases (LIFE), University of Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Wohland","sequence":"additional","affiliation":[{"name":"Leipzig University Medical Center, Integrated Research and Treatment Center (IFB) AdiposityDiseases, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Schleinitz","sequence":"additional","affiliation":[{"name":"Leipzig University Medical Center, Integrated Research and Treatment Center (IFB) AdiposityDiseases, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Fasshauer","sequence":"additional","affiliation":[{"name":"University of Leipzig, Department of Endocrinology and Nephrology, Leipzig, Germany"},{"name":"Leipzig University Medical Center, Integrated Research and Treatment Center (IFB) AdiposityDiseases, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bl\u00fcher","sequence":"additional","affiliation":[{"name":"University of Leipzig, Department of Endocrinology and Nephrology, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stumvoll","sequence":"additional","affiliation":[{"name":"University of Leipzig, Department of Endocrinology and Nephrology, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kovacs","sequence":"additional","affiliation":[{"name":"Leipzig University Medical Center, Integrated Research and Treatment Center (IFB) AdiposityDiseases, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"T\u00f6njes","sequence":"additional","affiliation":[{"name":"University of Leipzig, Department of Endocrinology and Nephrology, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"issue":"9945","key":"2020071621282476900_B1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"2020071621282476900_B2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N Engl J Med"},{"issue":"10046","key":"2020071621282476900_B3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","article-title":"Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents","volume":"388","author":"Di Angelantonio","year":"2016","journal-title":"Lancet"},{"issue":"16","key":"2020071621282476900_B4","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"7","key":"2020071621282476900_B5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.tips.2015.04.014","article-title":"Adipokines in health and disease","volume":"36","author":"Fasshauer","year":"2015","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"2020071621282476900_B6","doi-asserted-by":"crossref","first-page":"e99785","DOI":"10.1371\/journal.pone.0099785","article-title":"Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation","volume":"9","author":"Flehmig","year":"2014","journal-title":"PLoS One"},{"issue":"9353","key":"2020071621282476900_B7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(03)12255-6","article-title":"Adiponectin and protection against type 2 diabetes mellitus","volume":"361","author":"Spranger","year":"2003","journal-title":"Lancet"},{"issue":"1\u20132","key":"2020071621282476900_B8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/prca.201100052","article-title":"Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders","volume":"6","author":"Lehr","year":"2012","journal-title":"Proteomics Clin Appl"},{"issue":"2","key":"2020071621282476900_B9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ijo.2015.157","article-title":"Association of metabolic parameters and rs726344 in FNDC5 with serum irisin concentrations","volume":"40","author":"Ebert","year":"2016","journal-title":"Int J Obes"},{"issue":"10","key":"2020071621282476900_B10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1055\/s-0034-1382078","article-title":"Relationship between serum levels of angiopoietin-related growth factor and metabolic risk factors","volume":"46","author":"Ebert","year":"2014","journal-title":"Horm Metab Res"},{"issue":"1","key":"2020071621282476900_B11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ejhg.2009.107","article-title":"Association of FTO variants with BMI and fat mass in the self-contained population of Sorbs in Germany","volume":"18","author":"T\u00f6njes","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"2020071621282476900_B12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12263-014-0449-8","article-title":"Role of genetic variants in ADIPOQ in human eating behavior","volume":"10","author":"Rohde","year":"2015","journal-title":"Genes Nutr"},{"issue":"2","key":"2020071621282476900_B13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1530\/JOE-12-0367","article-title":"Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans","volume":"216","author":"Kralisch","year":"2013","journal-title":"J Endocrinol"},{"issue":"7","key":"2020071621282476900_B14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"2","key":"2020071621282476900_B15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00421-003-0796-4","article-title":"Hemodynamics during active and passive recovery from a single bout of supramaximal exercise","volume":"89","author":"Crisafulli","year":"2003","journal-title":"Eur J Appl Physiol"},{"issue":"9","key":"2020071621282476900_B16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"12","key":"2020071621282476900_B17","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/bioinformatics\/btl117","article-title":"Pvclust: an R package for assessing the uncertainty in hierarchical clustering","volume":"22","author":"Suzuki","year":"2006","journal-title":"Bioinformatics"},{"issue":"38","key":"2020071621282476900_B18","doi-asserted-by":"crossref","first-page":"28175","DOI":"10.1074\/jbc.M700793200","article-title":"Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism","volume":"282","author":"Goralski","year":"2007","journal-title":"J Biol Chem"},{"issue":"11","key":"2020071621282476900_B19","doi-asserted-by":"crossref","first-page":"e13911","DOI":"10.1371\/journal.pone.0013911","article-title":"Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes","volume":"5","author":"T\u00f6njes","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"2020071621282476900_B20","first-page":"41","article-title":"Different associations of adipokines in lean and healthy adults","volume":"46","author":"Ebert","year":"2014","journal-title":"Horm Metab Res"},{"issue":"2","key":"2020071621282476900_B21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-09-0380","article-title":"Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis","volume":"161","author":"Lehrke","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2020071621282476900_B22","doi-asserted-by":"crossref","first-page":"E506","DOI":"10.1152\/ajpendo.00586.2009","article-title":"Insulin-sensitive obesity","volume":"299","author":"Kl\u00f6ting","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"2020071621282476900_B23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2337\/dc11-1267","article-title":"Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention","volume":"35","author":"Bl\u00fcher","year":"2012","journal-title":"Diabetes Care"},{"issue":"6","key":"2020071621282476900_B24","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2003-031777","article-title":"Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies","volume":"89","author":"Baratta","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071621282476900_B25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","article-title":"Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex","volume":"46","author":"Cnop","year":"2003","journal-title":"Diabetologia"},{"issue":"2","key":"2020071621282476900_B26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2006.08.028","article-title":"Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia","volume":"193","author":"Nakamura","year":"2007","journal-title":"Atherosclerosis"},{"issue":"5","key":"2020071621282476900_B27","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"issue":"1","key":"2020071621282476900_B28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/dc12-0703","article-title":"Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians","volume":"36","author":"Bobbert","year":"2013","journal-title":"Diabetes Care"},{"issue":"11","key":"2020071621282476900_B29","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"issue":"1","key":"2020071621282476900_B30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-012-2737-4","article-title":"Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease","volume":"56","author":"Kralisch","year":"2013","journal-title":"Diabetologia"},{"issue":"9","key":"2020071621282476900_B31","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.numecd.2014.03.006","article-title":"Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction","volume":"24","author":"Ebert","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"2020071621282476900_B32","doi-asserted-by":"crossref","first-page":"e004974","DOI":"10.1161\/JAHA.116.004974","article-title":"Prospective relation of circulating adipokines to incident metabolic syndrome: the Framingham Heart Study","volume":"6","author":"Zachariah","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"2020071621282476900_B33","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1158\/1055-9965.EPI-07-0374","article-title":"Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies","volume":"16","author":"Lee","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/3\/1015\/24262732\/jc.2017-02085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/3\/1015\/24262732\/jc.2017-02085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T08:55:56Z","timestamp":1594976156000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/3\/1015\/4794883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-02085","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2018,1,9]]}}}